Pre-earnings options volume in Bionano Genomics is normal with calls leading puts 12:1. Implied volatility suggests the market is anticipating a move near 14.3%, or 18c, after results are released. Median move over the past eight quarters is 4.7%.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BNGO:
- Bionano Genomics announces publication of results from OGM trial
- Bionano Genomics options imply 13.9% move in share price post-earnings
- Bionano Genomics obtains class I registrations from China’s NMPA
- Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies
- Bionano Shares Overview of AGBT Pre-Conference Workshop Program Along with Details of Company’s Innovative Research Grant Opportunity